Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Latzinos is a Greek-based company specializing in the production and supply of authentic mastic gum, a natural resin harvested from the Pistacia lentiscus tree. The company serves as a key supplier to the pharmaceutical, nutraceutical, and personal care industries, providing bioactive ingredients known for their antimicrobial and anti-inflammatory properties. Latzinos' products are primarily utilized in formulations targeting gastrointestinal health, specifically for the treatment of Helicobacter pylori infections and stomach ulcers, as well as in natural oral care applications. The company gained further international prominence through a 2020 strategic partnership with Gum Technology Corporation to integrate its high-purity mastic gum into specialized oral hygiene and stabilization products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Latzinos.